Advertisement
Nimmagadda Prasad
Premium
General
30 April, 2024
Grapevine: CX Partners starts Veeda Clinical sale process; Ola CEO departs amid job cuts
CX Partners, a mid-market private equity firm, has started the process to divest its majority stake in Veeda Clinical Research, an ......
Premium
Healthcare
03 January, 2024
Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition
Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, which hit a first close of ......
Advertisement
Recommended for you
Advertisement